A Study of Recombinant Human Albumin Injection to Treat Hypoalbuminemia in Cirrhotic Patients With Ascites

NCT06911554 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

416

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Ascites

Interventions

BIOLOGICAL: Recombinant Human Albumin Injection
BIOLOGICAL: Human Albumin

Sponsor

Tonghua Anrate Biopharmaceutical Co., Ltd.

Collaborators

[object Object]